Jessica Sacher

@jessicasacher.bsky.social

phage therapy scientist at Stanford, building community at Phage Directory, writing about adventures from the lab to the clinic -> https://jess.bio

1/ AI can design biology faster than wet labs can build it. What if the wet lab fit on a hospital countertop? Invitris (a 2018 iGEM spinout from TU Munich) is testing how far cell-free phage production can go.

Bild

1/ "Why can't phage companies attract $400M rounds?" Locus Bio CEO Paul Garofolo thinks the answer is uncomfortable: too many small, underpowered trials producing mediocre data have cooled investor confidence across the whole field. Why? And how do we fix it?

Bild

1/ Chip Schooley (cofounder of UCSD's IPATH) was there when HIV went from “some people benefit” to functionally cured. His take: phage therapy is at about 1988 on that timeline. How do we get it into the 90s?

Bild

Excited to see @dariavantyne.bsky.social and Van Tyne Lab featured on the Podovirus Podcast! Great conversation on how translational phage work actually gets done. 🧫 Check out the links below for the full story! #pittsburghphageprogram #p3 #phages #infectiousdiseases #phagetherapy

Jessica Sacher@jessicasacher.bsky.social · 7mo ago

In 2018, @dariavantyne.bsky.social started her phage lab at @pittdeptofmed.bsky.social. She had 0 phages, just knew their biology & wanted to help patients. Today her lab makes phage for dozens of patients/year under compassionate use, while still publishing research. We asked Daria: HOW? 🧵1/